An observational study in Refractory Epilepsy, sponsored by University Hospital, Ghent. Completed. Per ClinicalTrials.gov, last updated 2021-08-18.
Sponsored by University Hospital, Ghent · Observational
Follow up of the patients at Ghent University Hospital treated with hippocampal DBS for refractory epilepsy.
Endpoints:
Patients with refractory epilepsy treated with hippocampal DBS
Exclusion Criteria:
Questionnaire for patient Questionnaire for neurologist
Other: Questionnaires
Questionnaire for patient: satisfaction regarding rechargeable DBS battery Questionnaire for neurologist: seizure frequency, satisfaction regarding rechargeable DBS battery
Seizure frequency per month based on seizure diary
Efficacy measured by reduction in seizure frequency before and after implantation
Time frame: Every six months (up to 2 years after implantation of rechargeable device)
Cognition
Cognition measured by neuropsychological testing
Time frame: Yearly (up to 2 years after implantation of rechargeable device)
Number of device problems
Reporting of device problems including long charging time, bad connection between device and charger, high frequency of charging (\> 1 time a day).
Time frame: Every six months (up to 2 years after implantation of rechargeable device)
Number of adverse events
Reporting of adverse events after implantation
Time frame: Every six months (up to 2 years after implantation of rechargeable device)
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Ghent